Learn more Read the press release Now providing you the powerful tools you need to fully understand the T-cell response in COVID-19 NOW AVAILABLE For Research Use Only. Not for use in diagnostic procedures. Learn more about the data Read the press release ImmuneCODE™ Launched De-identified COVID-19 immune response data available to help accelerate solutions to the pandemic 416,556,789 TCRs Sequenced 3,189 Samples
Learn more
Developing Therapeutic Antibodies Against COVID-19
Every immune system has a story to tell. The key is knowing how to listen. At Adaptive, we’re writing the next chapter of precision health — powered by immune-driven medicine.
Learn more
Read our press release clonoSEQ is available as an FDA-cleared in vitro diagnostic (IVD) test service provided by Adaptive Biotechnologies for use in acute lymphoblastic leukemia and multiple myeloma patients to detect measurable residual disease (MRD) in human bone marrow samples. clonoSEQ is also available for use in other lymphoid cancers as a CLIA-regulated laboratory developed test (LDT) service provided by Adaptive Biotechnologies. clonoSEQ is only available by prescription from a licensed healthcare professional. For important information about the FDA-cleared clonoSEQ IVD test service, including the full intended use, limitations, and detailed performance characteristics, please visit clonoSEQ.com/IFU. Medicare now covers the clonoSEQ® Assay for MRD monitoring in patients with Chronic Lymphocytic Leukemia (CLL)* *Not FDA-cleared; available as a CLIA-regulated laboratory developed test (LDT).

Pioneers in immune-driven medicine

Our goal is to meaningfully improve people’s lives by learning from the wisdom of their adaptive immune systems. It’s a bold objective that we’re uniquely built to achieve.


The evolution of our immune-driven medicine platform

The adaptive immune system is nature’s most finely tuned diagnostic and therapeutic. Our platform reveals its enormous diversity and scale.


Become an Adapter

We’re looking for curious, passionate people to help us write the future of immune-driven medicine.

Convergent Team

Juxtaposing disciplines leads to discoveries in our field.

Innovative Thinkers

Open minds explore the unimaginable.


Pioneering spirit makes us first to break new ground.

 Keep up to date with Adaptive. Join our newsletter.